Momento
+35%
est. 2Y upside i
Building a full-stack auto insurer for the underserved in LatAm
Rank
#2284
Sector
Insurtech
Est. Liquidity
~5Y
Data Quality
Data: LowMomento is a credible insurtech bet with genuine institutional backing and a licensed carrier credential — not just a tech wrapper — but a job candidate joining at Series A should calibrate expectations carefully: all revenue and valuation figures are undisclosed, the $21.2M preference stack is severe (estimated ~47% of entry valuation), and realistic liquidity is 5+ years out.
Last updated: May 14, 2026
Momento captures meaningful share of Mexico's $2.6B SAM, reaching $30-40M in gross written premium by 2027-2028 and raising a Series B at a $120-150M valuation — roughly 3x the estimated ~$45M Series A post-money. AM Best credibility accelerates distribution partnerships and common equity participates materially once the $21.2M preference stack clears.
Steady but moderate growth in Mexico; Momento raises a Series B at $60-70M around 2028, implying ~40-55% paper appreciation from estimated entry — but after one additional dilution round (~20%) and the $21.2M preference overhang, employee common stock net gain lands closer to 25-30%. No liquidity event occurs within the 2-year window.
MXN depreciation, elevated claims loss ratios, or capital reserve requirements force a down round or operational crunch by late 2027; the $21.2M preference stack absorbs most recovery value in any restructuring, leaving employee common equity worth approximately 20-25 cents on the dollar relative to entry.
Preference Stack Risk
severeFunding Intensity
4700%Total funding of $21.2M sits against an estimated Series A post-money valuation of ~$45M (no actual valuation disclosed), implying roughly 47% of the company's current enterprise value is absorbed by liquidation preferences before common shareholders receive any proceeds.
Dilution Risk
highAs a capital-intensive licensed insurance carrier still in growth mode with no disclosed profitability, Momento will almost certainly require at least one additional funding round (Series B) within the 2-year window, diluting employee common stock by an estimated 18-25%.
Secondary Liquidity
noneAt Series A stage with 71 employees and no disclosed secondary market activity or tender offer program, there is no realistic secondary liquidity pathway within a 2-year horizon.
Questions to Ask at the Interview
Strategic questions based on Momento's data — designed to show you've done your homework.
- 1
“What is your current gross written premium run rate, monthly active policy count, and combined loss ratio — and how have these trended over the last four quarters?”
- 2
“How does your AI underwriting model produce a differentiated loss ratio versus incumbents like Quálitas and AXA Mexico, and what proprietary data makes that advantage defensible as competitors invest in digitization?”
- 3
“What are the exact vesting schedule, strike price relative to the Series A post-money, and liquidation preference terms on the employee equity plan — and has the board authorized any secondary liquidity window for early employees?”
Community
Valuation Sentiment
Our model estimates +35% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.